⌘K

Home/Filings/SCHEDULE 13D/A/0001373604-25-000092

SCHEDULE 13D/A//SEC Filing

AN2 Therapeutics, Inc. SCHEDULE 13D/A

Accession 0001373604-25-000092

CIK 0001373604other

View on SEC.gov Company Profile

Filed

Jun 17, 8:00 PM ET

Accepted

Jun 18, 11:08 AM ET

Size

9.0 KB

Accession

0001373604-25-000092

Documents

1 file

SCHEDULE
primary_doc.xml

Issuer

BML Investment Partners, L.P.

CIK 0001373604

Entity typeother

IncorporatedDE

Related Parties

1

filerCIK 0001373604

Filing Metadata

Form type: SCHEDULE 13D/A
Filed: Jun 17, 8:00 PM ET
Accepted: Jun 18, 11:08 AM ET
Size: 9.0 KB

View on SEC.gov